FDA Investigator: Barbara D. Paul
- Barbara D. Paul first started conducting FDA inspections in 2001, with the last inspection in 2014. Over that time, Barbara D. Paul has conducted 31 inspections at 28 companies across 31 sites.
Get Barbara Paul's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Aurobindo Pharma Limited - Unit IV, Medak District, Hyderabad | 2014
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main | 2013
Out-of-stock
Barbara D. Paul
Medical Devices & Rad Health Form 483
FDA 483 Sanofi-Aventis Deutschland GmbH, Frankfurt am Main | 2013
Out-of-stock
Barbara D. Paul
Medical Devices & Rad Health Form 483
FDA 483 Health Protection Agency, Salisbury | 2013
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Public Health England, Salisbury | 2013
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Pierre Fabre Medicament Production, Idron | 2013
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Pierre Fabre Medicament Production, Idron | 2013
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Schering Plough Sante Animale, Segre | 2012
Out-of-stock
Barbara D. Paul
Animal Drugs & Feed Form 483
FDA 483 Nycomed GmbH a Takeda Company, Singen (hohentwiel) | 2012
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Intas Pharma Limited, SEZ, Ahmedabad | 2011
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Intas Pharmaceuticals Limited, Ahmedabad City | 2011
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Orchid Chemicals & Pharmaceuticals Ltd., Alathur, Kancheepuram District | 2010
Out-of-stock
Barbara D. Paul
Animal Drugs & Feed Form 483
FDA 483 LEK Pharmaceuticals d.d., Ljubljana | 2009
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Biocon Limited, Bangalore, Karnataka State | 2009
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 NerPharMa S.r.l., Nerviano Milano | 2008
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Gruppo Lepetit Srl, Anagni | 2008
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Wockhardt Limited, Aurangabad, Maharashtra 431 210 | 2008
Out-of-stock
Barbara D. Paul
Human Drug Form 483
FDA 483 Wockhardt Limited, Aurangabad, Maharashtra State | 2008
Out-of-stock
Barbara D. Paul
Human Drug Form 483
Co-Investigators (21)
- Nebil A. Oumer, FDA Investigator
- Michelle J. Glembin, FDA Investigator
- Sandra A. Hughes, FDA Investigator
- Julianne C. McCullough, FDA Investigator
- Robert J. Martin, FDA Investigator
- Marie F. Morin, FDA Investigator
- Neil J. Bonzagni, FDA Investigator
- Atul Agrawal, FDA Investigator
- Roy C. Stephens, FDA Investigator
- Regina T. Brown, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Douglas A. Campbell, FDA Investigator
- Melissa J. Garcia, FDA Investigator
- Paraluman S. Leonin, FDA Investigator
- John A. Podsadowski, FDA Investigator
- Douglas C. Kovacs, FDA Investigator
- Simone E. Pitts, FDA Investigator
- Felix Maldonado, FDA Investigator
- Kevin A. Gonzalez, FDA Investigator
- Evelyn Taha, FDA Investigator
- Yuan Hu, FDA Investigator